Search Results
Abstracts
Starting PrEP during acute HIV infection: what is the risk for antiretroviral drug resistance?
Presented at:
APACC 2019
Slidesets
Philippa Easterbrook_COLDA2024.pdf
Presented at:
Conference on Liver Disease in Africa (COLDA) 2024
Slidesets
The Role of Social and Structural Determinants on Access to PrEP | Michael Meulbroek
Presented at:
European Meeting on HIV & Hepatitis 2024
Slidesets
Challenges and Triumphs of Pediatric HIV Care and Treatment in West/Central Africa- Didier Ekouevi, MD, PhD
Presented at:
International Workshop on HIV & Pediatrics 2017
Abstracts
Baseline gut-associated microbial signatures may help predict HIV-1 viral control after treatment interruption
A. Borgognone
Presented at:
International Workshop on Microbiome in HIV Pathogenesis, Prevention and Treatment 2020
Slidesets
Formal Debate: Resolved that 90-90-90 Cannot be Attained | Affirming the motion | Mauro Schechter, MD, PhD
Presented at:
INTEREST 2016